Literature DB >> 24914675

Measurements of droplet size distribution and analysis of nasal spray atomization from different actuation pressure.

Kiao Inthavong1, Man Chiu Fung, William Yang, Jiyuan Tu.   

Abstract

BACKGROUND: To evaluate the deposition efficiency of spray droplets in a nasal cavity produced from a spray device, it is important to determine droplet size distribution, velocity, and its dispersion during atomization. Due to the limiting geometric dimensions of the nasal cavity airway, the spray plume cannot develop to its full size inside the nasal vestibule to penetrate the nasal valve region for effective drug deposition.
METHODS: Particle/droplet image analysis was used to determine local mean droplet sizes at eight regions within the spray plume under different actuation pressures that represent typical hand operation from pediatric to adult patients.
RESULTS: The results showed that higher actuation pressure produces smaller droplets in the atomization. Stronger actuation pressure typical of adult users produces a longer period of the fully atomized spray stage, despite a shorter overall spray duration. This produces finer droplets when compared with the data obtained by weaker actuation pressure, typical of pediatric users.
CONCLUSION: The experimental technique presented is able to capture a more complete representation of the droplet size distribution and the atomization process during an actuation. The measured droplet size distribution produced can be related to the empirically defined deposition efficiency curve of the nasal cavity, allowing a prediction of the likely deposition.

Entities:  

Keywords:  automated actuation; nasal drug delivery; particle/droplet image analysis; spray atomization; spray pattern

Mesh:

Substances:

Year:  2014        PMID: 24914675     DOI: 10.1089/jamp.2013.1093

Source DB:  PubMed          Journal:  J Aerosol Med Pulm Drug Deliv        ISSN: 1941-2711            Impact factor:   2.849


  8 in total

1.  First Steps to Develop and Validate a CFPD Model in Order to Support the Design of Nose-to-Brain Delivered Biopharmaceuticals.

Authors:  Lucas Engelhardt; Martina Röhm; Chrystelle Mavoungou; Katharina Schindowski; Annette Schafmeister; Ulrich Simon
Journal:  Pharm Res       Date:  2016-02-17       Impact factor: 4.200

2.  Importance of Spray-Wall Interaction and Post-Deposition Liquid Motion in the Transport and Delivery of Pharmaceutical Nasal Sprays.

Authors:  Arun V Kolanjiyil; Ali Alfaifi; Ghali Aladwani; Laleh Golshahi; Worth Longest
Journal:  Pharmaceutics       Date:  2022-04-28       Impact factor: 6.525

3.  Numerical evaluation of spray position for improved nasal drug delivery.

Authors:  Saikat Basu; Landon T Holbrook; Kathryn Kudlaty; Olulade Fasanmade; Jihong Wu; Alyssa Burke; Benjamin W Langworthy; Zainab Farzal; Mohammed Mamdani; William D Bennett; Jason P Fine; Brent A Senior; Adam M Zanation; Charles S Ebert; Adam J Kimple; Brian D Thorp; Dennis O Frank-Ito; Guilherme J M Garcia; Julia S Kimbell
Journal:  Sci Rep       Date:  2020-06-29       Impact factor: 4.379

4.  Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets.

Authors:  Jasmina M Luczo; Tatiana Bousse; Scott K Johnson; Cheryl A Jones; Nicholas Pearce; Carlie A Neiswanger; Min-Xuan Wang; Erin A Miller; Nikolai Petrovsky; David E Wentworth; Victor Bronshtein; Mark Papania; Stephen M Tompkins
Journal:  NPJ Vaccines       Date:  2021-04-21       Impact factor: 7.344

Review 5.  Nasally inhaled therapeutics and vaccination for COVID-19: Developments and challenges.

Authors:  Jinxiang Xi; Lameng Ray Lei; William Zouzas; Xiuhua April Si
Journal:  MedComm (2020)       Date:  2021-12-14

6.  Liquid Film Translocation Significantly Enhances Nasal Spray Delivery to Olfactory Region: A Numerical Simulation Study.

Authors:  Xiuhua April Si; Muhammad Sami; Jinxiang Xi
Journal:  Pharmaceutics       Date:  2021-06-18       Impact factor: 6.321

7.  Nasal sprayed particle deposition in a human nasal cavity under different inhalation conditions.

Authors:  Hadrien Calmet; Kiao Inthavong; Beatriz Eguzkitza; Oriol Lehmkuhl; Guillaume Houzeaux; Mariano Vázquez
Journal:  PLoS One       Date:  2019-09-06       Impact factor: 3.240

8.  Between-Batch Bioequivalence (BBE): a Statistical Test to Evaluate In Vitro Bioequivalence Considering the Between-Batch Variability.

Authors:  Jonathan Bodin; Stéphanie Liandrat; Gabriel Kocevar; Céline Petitcolas
Journal:  AAPS J       Date:  2020-09-10       Impact factor: 4.009

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.